rs201263733
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_018100.4(EFHC1):c.916A>G(p.Lys306Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,614,088 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_018100.4 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- juvenile myoclonic epilepsyInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- epilepsyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| EFHC1 | NM_018100.4 | c.916A>G | p.Lys306Glu | missense_variant, splice_region_variant | Exon 5 of 11 | ENST00000371068.11 | NP_060570.2 | |
| EFHC1 | NM_001172420.2 | c.859A>G | p.Lys287Glu | missense_variant, splice_region_variant | Exon 6 of 12 | NP_001165891.1 | ||
| EFHC1 | NR_033327.2 | n.2242A>G | splice_region_variant, non_coding_transcript_exon_variant | Exon 4 of 10 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152212Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000358 AC: 9AN: 251320 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461758Hom.: 0 Cov.: 34 AF XY: 0.0000124 AC XY: 9AN XY: 727186 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152330Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74498 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Absence seizure;C1850778:Myoclonic epilepsy, juvenile, susceptibility to, 1 Uncertain:1
This variant has not been reported in the literature in individuals affected with EFHC1-related conditions. This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 306 of the EFHC1 protein (p.Lys306Glu). This variant is present in population databases (rs201263733, gnomAD 0.05%). ClinVar contains an entry for this variant (Variation ID: 197833). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at